 |
|
Novel model of osteosarcoma
June 16, 2008In the June 15th issue of G&D, Dr. Stuart Orkin (HHMI, Dana-Farber Cancer Institute, Children's Hospital Boston) and colleagues present a new mouse model of osteosarcoma.
Osteosarcoma is the most common type of malignant bone cancer, and one of the most lethal: The 5-year survival rate is only about 60%, and this statistic drops steeply once the cancer spreads. Osteosarcoma results from the dysregulated growth of osteoblasts (the cells that form the bone matrix). It primarily develops near the ends of the femur, tibia or humerus, and is usually diagnosed during adolescence, when the long bones of the body are undergoing rapid growth.
While the precise causes of osteosarcoma are unknown, it is evident that two tumor suppressor genes - p53 and Rb - are involved, as children with familial mutation syndromes affecting either of these genes have higher incidences of osteosarcoma.
Dr. Orkin's team has developed a novel experimental system to model the genetics of human osteosarcoma. The researchers generated a strain of transgenic mice lacking specifically the p53 and Rb genes in an early osteoblast progenitor cell population. All mutant animals rapidly developed osteosarcomas, with clinical, histo-cytological and molecular features closely recapitulating the human disease.
The scientists concluded that p53 loss is essential for the development of osteosarcoma, and that while Rb gene mutation acts synergistically with p53 loss to facilitate carcinogenesis, loss of Rb, alone, is not sufficient to induce osteosarcomagenesis.
Ultimately, this high-fidelity animal model will further elucidate the genetic contributions to osteosarcoma, and enable researchers to rationally design and test new therapies. Dr. Orkin is hopeful that "our work will stimulate translational efforts to develop novel therapies for this devastating bone tumor".
Cold Spring Harbor Laboratory
Dr. Orkin's team has developed a novel experimental system to model the genetics of human osteosarcoma. The researchers generated a strain of transgenic mice lacking specifically the p53 and Rb genes in an early osteoblast progenitor cell population. All mutant animals rapidly developed osteosarcomas, with clinical, histo-cytological and molecular features closely recapitulating the human disease.
The scientists concluded that p53 loss is essential for the development of osteosarcoma, and that while Rb gene mutation acts synergistically with p53 loss to facilitate carcinogenesis, loss of Rb, alone, is not sufficient to induce osteosarcomagenesis.
Ultimately, this high-fidelity animal model will further elucidate the genetic contributions to osteosarcoma, and enable researchers to rationally design and test new therapies. Dr. Orkin is hopeful that "our work will stimulate translational efforts to develop novel therapies for this devastating bone tumor".
Cold Spring Harbor Laboratory
Osteosarcoma Current Events and Osteosarcoma News RSSSame process discovered to both form skeleton and protect it for life
A protein signaling pathway recently discovered to guide the formation of the skeleton in the fetus also keeps bones strong through adult life, according to two papers published recently in the journal Nature Medicine.
Study shows drug effective in treating, preventing breast cancer
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
Researchers find that childhood sarcoma increases risk of blood clots
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins.
Insights into osteosarcoma in cats and dogs may improve palliative care
Researchers at the University of Illinois have found that a molecular pathway known to have a role in the progression of bone cancer in humans is also critical to the pathology of skeletal tumors in dogs and cats.
Childhood cancer survivors at increased risk of sarcoma
Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma—a cancer of connective or supportive tissue such as bone, fat, or muscle—compared with the general population.
No benefit to increasing dose intensity of chemotherapy in osteosarcoma, study finds
A dose-intensive regimen of the chemotherapy drugs cisplatin and doxorubicin offered no clinical benefit over standard doses of the chemotherapy drugs in patients with a bone cancer called osteosarcoma, according to results from a randomized trial in the January 17 issue of the Journal of the National Cancer Institute.
Hearing loss from chemotherapy underestimated
By 14, Peter Johnson had survived brain cancer and a relapse of the disease in his shoulder. But it was treatment for the last tumor that would create his life's greatest challenges.
Nuclear reactor as a cancer cure
Despite the millions of dollars that have been invested into research to improve methods of treatments for various types of cancer, oncological diseases continue to have a high mortality rate, remaining one of the main causes of death globally. Traditional cancer treatment methods, such as chemotherapy, immunotherapy, and radiotherapy are effective in approximately only half of all patients.
Adolescent survival rates for osteosarcoma have not improved for 20 years
More research is urgently needed says cancer surgeon London, UK: New treatments and more research are urgently needed in order to increase the numbers of adolescents who survive bone cancer, according to a leading cancer surgeon. Osteosarcoma is the third most common cancer in young people*, yet during the past 20 years little research has been carried out into developing improved therapies, and survival rates have remained unchanged with only 54 per cent of patients alive after five years, says Robert Grimer, a consultant orthopaedic oncologist at The Royal Orthopaedic Hospital NHS Trust in Birmingham. He will tell the Teenage Cancer Trust's Third International Conference on Cancer and th
Specific treatments for each type of sarcoma
The new molecular techniques allow designing specific treatments for a great number of sarcomas, according to Dr. Enrique de Alava, expert of the department of Pathologic Anatomy of the University Clinic of the University of Navarre. The molecular knowledge has become a very useful tool to study several diseases. In particular, it provides complementary tools for the diagnosis, allows determining the prognosis of sarcomas and also understanding better the tumour process in general. One of the fields in which the techniques of molecular biology are applied is the diagnosis of sarcomas. This term includes several types of tumours, many of which have very specific genetic alterations that allo
More Osteosarcoma Current Events and Osteosarcoma News Articles
 | Apollo's Creed by Deb Estes The story of the fight for time - against a killer of pets - cancer. Did they just tell you that your best friend is very sick? Apollo's creed and legacy to you is to help you find all the resources and treatment options possible for your pet to make him/her feel better as they fight the battle for their life. And if the time comes where you have to say good-by... you'll be able to face... |
 | Osteosarcoma Medical Guide by Qontro Medical Guides The Osteosarcoma Medical Guide is a publication which has been designed to better help readers understand Osteosarcoma. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Osteosarcoma. The Osteosarcoma Medical Guide is highly recommended for those interested in understanding and learning... |
| Case of Osteo-Sarcoma of the lower Jaw. by James SYME | |
| Osteosarcoma (Clinical Orthopaedics & Related Research, Vol 111) | |
| Clinical Orthopaedics and Related Research - #270 - Newest Knowledge of Osteosarcoma by Marshall R. (Editor-in-Chief) Urist | |
| ONC2 Multiple drug resistance markers MDR-1, MRP, LRP in osteosarcoma. (Oncology).(Brief Article): An article from: Southern Medical Journal This digital document is an article from Southern Medical Journal, published by Southern Medical Association on December 1, 2001. The length of the article is 393 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Osteosarcoma: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed. by Kenneth, M.D. Berniker, Abigail, B.A. Berniker Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic... | |
| Osteosarcoma: a lethal threat: early detection of this death-dealing cancer can extend the life of a stricken animal. Here's what you should kow.(Disease): An article from: Cat Watch by Tom Ewing This digital document is an article from Cat Watch, published by Thomson Gale on May 1, 2007. The length of the article is 921 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Osteosarcoma: a... | |
| Gale Encyclopedia of Cancer: Osteosarcoma by M.Sc. Wendy Wippel The article is excerpted from Gale Encyclopedia of Cancer The resource students and researchers will turn to for reliable, up-to-date and clearly written information, the Gale Encyclopedia of Cancer is a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures. The Encyclopedia includes entries covering cancers, cancer drugs,... | |
 | The Official Parent's Sourcebook on Osteosarcoma: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for parents who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells parents where and how to look for information covering virtually all topics related to osteosarcoma (also Histiocytoma bone; Osteogenic; Osteogenic sarcoma;... |
| © 2009 BrightSurf.com |